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Thresholds for Transesophageal 
Atrial Pacing 
Macdonald Dick II, MD, Robert M. Campbell, MD, and 
Janice M. Jenkins, PhD 
To determine the thresholds for transesophageal atrial capture, as well as factors 
that may influence the thresholds, we measured the minimal current and pulse width 
required to pace the atria through transesophageal bipolar lead systems in 12 pa- 
tients, ranging in age from l day to 19 years, during 19 episodes of reentrant 
supraventricular tachycardia. Depending on the patients’ age and size several elec- 
trode catheters were used. The protocol called for 1-msec step-wise increments in 
pulse width. At each pulse width the current was increased by 1 mamp until capture 
was achieved. The mean minimal pulse width and mean minimal current required for 
capture were 5.8 msec and 13.6 mamp, respectively. Atrial capture was achieved in 
75% of attempts at a pulse width and current equal to or less than 6.5 msec and 17.5 
mamp, respectively. No correlation between current and pulse width on the one hand 
and age, height, weight, or body surface area on the other was detected. Likewise 
neither electrode type nor existence of structural heart disease influenced the thresh- 
old required for capture. We conclude that atrial capture can be readily achieved 
through transesophageal electrodes and is not influenced by the subject’s age or 
size. 
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INTRODUCTION 
We and others have reported the use of transesophageal pacing for conversion of 
reentrant supraventricular tachycardia as well as the route for delivery of programmed 
extrastimulation for measurement of electrophysiologic and hemodynamic responses 
[l-71. This technique is dependent on the proximity of the esophagus to the heart. 
Limited information on the relationship between impulse strength and duration for 
transesophageal cardiac pacing in man exists [4,8]; however, little data is available 
that examines the possible relationships between threshold for atrial capture through 
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the esophagus and the subject’s age, size, underlying heart disease, or type of 
electrode lead. It has been estimated that current density delivered to the atrium by 
the esophageal lead is about 4% of that from an intracavitary lead [8]; because atrial 
capture can usually be achieved through an intracavitary lead with equal to or less 
than 1 mamp current (at a pulse width of 2 msec), a current of approximately 25 
mamps appears to be necessary to produce cardiac current density sufficient to pace 
the heart through an esophageal electrode. This estimation applies to both unipolar 




J = -  
the current density, J, at the target site is dependent on the current delivered, I, half 
the interelectrode distance, d,  and the distance of the electrode from the excitable 
tissue, R. Because the current density at the site of capture, when using a bipolar 
lead, is inversely related to the distance between the current source and the target 
tissue cubed [8], it is clear that a small change in this distance would alter the 
threshold of capture. To examine for the effect of patients’ age, and size, as indices 
of the distance between the esophagus and the atrial tissue, we measured the minimal 
current (mamps) and pulse width (msec) in 12 patients during 19 episodes of reentrant 
supraventricular tachycardia. In this report we describe the technique of transesopha- 
geal atrial pacing, examine the distance to current-source relationship, and outline the 
threshold requirements for successful capture in man. 
PATIENTS AND METHODS 
The clinical and threshold data in the 12 patients studied are summarized in Table 
I. These 12 patients experienced 19 episodes of reentrant supraventricular tachycardia 
requiring pacing conversion. Nine of the episodes were paroxysmal supraventricular 
tachycardia and 10 were atrial flutter. There were six males and six females. The ages 
ranged from 1 week to 19 years, the weight from 4 to 91 kg, and the height from 38 
to 190 cm. Informed written consent was obtained from each patient and/or parents 
when appropriate. 
Depending on the age and size of the patient various electrode catheters were used. 
For the fully cooperative, older, nonsedated outpatient a pill electrode (Arzco Medical 
Electronics, Inc., Chicago, IL), with an interelectrode distance of 6.5 mm, was 
swallowed. The electrode was then allowed to pass by peristaltic motion, initiated by 
the swallowing of small sips of water, into the stomach. For infants, after estimating 
the nares-to-stomach distance on the body surface, a 4 French soft bipolar electrode 
catheter was gently passed through the nasopharynx and esophagus and advanced into 
the stomach. Alternatively, a 5 French quadripolar catheter (the electrode configura- 
tion is two electrodes 1 mm apart at the tip, then two more electrodes 1 mm apart 10 
cm proximal to the most distal pair) was passed through a 8-10 French suction 
catheter into the stomach. In older children the nasopharynx was anesthetized with 
xylocaine viscous and posterior oral pharynx by an aersol anesthetic spray and the 
suction catheter was coated with lubricant. Prior to passage of the catheters the 
distance from the nares to the stomach was carefully estimated; likewise the distance 
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Threshold Catheter type/ 
Episode/ Age Current Pulse width interelectrode 
Patient (yr) Arrhythmia (mamp) (msec) distance 
TABLE I .  Clinical and Threshold Data 
- 
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4 Fr/lO rnm 
4 Fr/lO mm 
Medl29 mm 
5 FrilO mm 
4 Fr/ 10 mrn 
“Pill”i6mm 
4 Fr/lO mm 
4 Fr/ 10 mm 
4 Fr/ 10 mm 
Medi29 mm 
5 Fr/lO mm 
Wt Ht BSA 
(kg) (cm) (m2)” 
14.5 90 0.5 
55.7 159 1.56 
55.7 159 1.56 
27.4 131 0.99 
26.6 131 0.99 
26.6 131 0.99 
33 135 1.11 
19.4 112 0.78 
4.2 55 0.24 
4.2 55 0.24 
25.7 1.52 1.09 
4.62 57.5 0.26 
4.03 38 0.18 
58 135 1.41 
3.68 51 0.22 
3.68 51 0.22 
3.68 51 0.22 
91.7 190 2.2 
11.58 81 0.49 
flutter 
“BSA, Body surface area. 
bFr, French. 
‘Med, Medtronic 6910R-58. 
dPSVT, Paroxysmal supraventricular tachycardia. 
required for extrusion of the electrodes beyond the suction catheter was carefully 
estimated and noted on the electrode catheter. Not infrequently the suction catheter 
required enlargement at the tip by creating a slit along the longitudinal axis of the tip 
of the catheter. The electrode catheter was then easily passed after lubrication through 
this suction catheter and positioned as previously described. This technique allowed 
the passage of a stiff, multielectrode catheter, minimizing discomfort and avoiding 
possible perforation. For five larger patients who declined the pill electrode, a soft 
transvenous pacemaker bipolar lead (Medtronic 6901R-58) with an interelectrode 
distance of 2.9 cm could be easily passed into the stomach. Once the recording and 
pacing catheter was in the stomach, the electrodes were then connected to standard 
an isolated amplifier (Electronics For Medicine V1205A) for display on an oscillo- 
scope as well as for recording on photographic paper moving at 50-100 mm/sec. Two 
to three standard electrocardiographic leads were simultaneously monitored and 
recorded. The lead was then slowly withdrawn until the optimal pacing location was 
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found. This position was indicated by noting the maximal recorded atrial electrogram, 
which was usually equal to or greater than 2-3 times the size of the ventricular 
electrogram. Because of the distance-current relationship previously described, a 
specially designed battery-powered constant-current stimulator (Arzco Medical Elec- 
tronics, Inc., Chicago, IL Model #5 esophageal stimulator) was used; this device 
provided a constant current pulse of 1-25 mamps and a constant pulse width of 1-10 
msec over a wide range of pacing cycle lengths. 
The protocol for determination of the threshold requirements was as follows: We 
began pacing a 4-msec pulse width and a 5-mamp current at 90% of the tachycardia 
cycle legth. The pulse width was then increased by 1-msec increments. At each pulse 
width setting the current was increased by a 1-mamp increment until capture was 
achieved. Thus the earliest point of capture indicated the minimal pulse width and 
minimal mamps required for pacing. 
Analysis of the data included calculation of the mean and standard deviation of the 
current and pulse width required for capture. In addition linear regression analysis 
between the pulse width and/or current on the one hand and age, weight, height, body 
surface area, and type of lead (ie, interelectrode distance) used on the other was 
performed. Finally, analysis of variance comparing the threshold requirements be- 
tween those subjects with normal hearts and those with structurally abnormal hearts 
was performed. 
RESULTS 
The results are summarized in Table 11. Among the 19 episodes of reentrant 
supraventricular tachycardia in these 12 patients the mean minimal pulse width 
required for capture was 5.8 msec, whereas the minimal current required for capture 
was 13.6 mamps. Distribution of the pulse width and current values demonstrated 
that capture was achieved in 75% of attempts when a pulse width of 6.5 msec and a 
current of 17.5 mamps was achieved. 
Linear regression analysis demonstrated that there was no correlation between the 
pulse width and the current at threshold on the one hand and the age, height, weight, 
body surface area, or type of lead used. Analysis of covariance demonstrated that no 
significant relationship was detected even when either pulse width or current was 
alternately held constant. Scattergrams between the threshold requirements on the one 
hand and the size and age variables on the other likewise failed to suggest a relation- 
ship. Analysis of variance demonstrated no significant difference in threshold between 
those patients with normal hearts and those with structurally abnormal hearts. 
TABLE II. Threshold in Pulse Width (PW) and 
Current 
Pulse width 5.8 2.2" rnsec 
current 13.6 k 3.8 rnarnp 
% Episodes successfully PW Current 
captured (< rnsec) ( Q rnarnp) 
25 % 4.0 10 
50 % 5.0 12.5 
75 % 6.5 17.5 
a% SD. 
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To examine for reproducibility within the same patient, coefficients of variation 
were calculated for the four subjects who had multiple determinations. The coefficient 
of variation for these four subjects was 52% for pulse width and 29% for current. If 
one excluded patient No. 2, who was minimally sedated and quite anxious at the first 
trial, thus making precise determination of the threshold difficult, the coefficient of 
variation was 15% for current and 18% for pulse width. 
DISCUSSION 
These data are in accord with thresholds used by other investigators in transesopha- 
geal cardiac stimulation in man [2-71 In addition, they are compatible with the 
theoretical considerations regarding the estimate of 25 mamps required for transeso- 
phageal stimulation. Finally, they demonstrate that, with only a moderate increase in 
pulse width above the widely used intracavitary pulse width of 2 msec, atrial capture 
through esophageal leads can often be achieved with almost a 50% decrease from the 
estimated 25 mamps. 
It is interesting to note that, despite the mathematical model describing the relation- 
ship between current density at the target site and distance between target site and 
current source, no relationship between the threshold requirements and the subject’s 
size was detected. We had initially speculated that, because of the inverse relationship 
between distance and current source, increasing age and size would result in an 
increasing distance between the target atrial wall and the electrode. Thus current 
density would be reduced and threshold requirements would increase with increasing 
age and size. Failure to conform to this mathematical model may be explained by a 
relative constancy of the distance between the esophagus and the atrial posterior wall 
despite the obvious changes in somatic size and configuration as well as a constant 
esophageal wall thickness that does not change appreciably with increasing age or 
size. 
Pulse width and current values required in this study were considerably below those 
thresholds required to produce hyperemia or epithelial erosion in canine experiments 
[8,9]. These experiments demonstrated that epithelial erosion, which self-repaired 
after 24 hr, appeared following pacing at 60 mamps at a pulse width of 2 msec for 4 
hr. When pacing was limited to less than 30 min no epithelial injury was noted [8,9]. 
It is important to consider that the cumulative time required for conversion of 
reentrant supraventricular tachycardia in these patients was less than 2 min. No single 
sustained pacing interval exceeded 30 sec. 
The threshold requirements over time in individual subjects appears reasonably 
constant given the variable placement of the catheter during each subsequent pacing 
conversion. It is possible that catheter movement could occur during pacing as a 
result of peristalsis and thus change the thresholds for pacing. These intrapatient data, 
along with the lack of correlation between patient age and size, suggest that the major 
determinant of successful transesophageal atrial capture is the identification of the 
optimal pacing site by recording the maximal atrial electrogram through the trans- 
esophageal leads. Because of possible lateral displacement of the electrode within the 
esophagus, several passes may be required to obtain the maximal atrial electrogram 
(usually equal to or greater than the ventricular electrogram) correctly identifying the 
optimal pacing site. 
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This experience indicates that the technique is safe and well tolerated by the subject. 
The only frequent sensation mentioned by the patient is that of esophageal discomfort 
or “heartburn” during pacing; this is transient, ceasing at the termination of pacing. 
This discomfort can be reduced by careful explanation of the procedure as well as the 
judicious use of sedation. Most babies tend to sleep during the procedure after 
positioning of the catheter. One patient had inadvertant passage of the catheter into 
the right main stem bronchus; severe coughing developed and the catheter was 
immediately withdrawn. Successful pacing was achieved when the catheter was 
correctly placed in the esophagus. Careful electrode catheter selection along with 
mucosal anesthesia reduces the discomfort during passage and reduces the risk of 
perforation of the esophagus. The risk of inadvertant ventricular stimulation is 
reduced by using catheters with an interelectrode distance of 6-10 mm and by careful 
selection of the optimal pacing site. In patients undergoing pacing studies while in 
sinus rhythm a rapid ventricular response during atrial pacing supported by either a 
“fast” atrioventricular node or an accessory connection with a short antegrade effec- 
tive refractory period is a theoretical drawback of this technique. Such a response, 
for the most part, can be prevented by examining the surface ECG in conjunction 
with the transesophageal electrocardiogram. In addition inadvertant induction of atrial 
fibrillation may occur; this possibility could be desirable as it may represent an 
unstable transient rhythm that spontaneously converts to sinus rhythm [ 10,111. In any 
event, as indicated by our data, the most likely outcome of introducing impulses 
during tachycardia is penetration of the reentrant circuit and the desired termination 
of the tachycardia. However, because these several possibilities exist, transesophageal 
atrial pacing should be performed only in facilities with immediate access to DC 
cardioversion. 
This study demonstrates that the threshold for transesophageal atrial pacing is 
independent of patient age, size, and cardiac structural abnormality. The technique is 
safe, requiring current and pulse width well below those that produce epithelial injury 
in experimental animals. It avoids direct current cardioversion, which creates diffuse 
myocardial injury, and thus is especially useful in those individuals requiring repeated 
conversions. We therefore recommend this procedure for patients who require car- 
dioversion for reentrant supraventricular tachycardias regardless of age, size, or 
underlying cardiac abnormality. 
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